Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Treatment-naïve Severe Aplastic Anemia”

3 trials

Showing 3 of 3 results

Not applicableStudy completedNCT07415083
What this trial is testing

The Safety and Effectiveness of Eltrombopag in Combination With Immunosuppressive Therapy (IST) in Korean Pediatric Patients With Treatment Naïve Severe Aplastic Anemia

Who this might be right for
Aplastic Anemia
Novartis Pharmaceuticals 13
Large-scale testing (Phase 3)Not Yet RecruitingNCT07345000
What this trial is testing

Romiplostim N01 Plus IST vs. Placebo Plus IST for Treatment-Naive Severe Aplastic Anemia

Who this might be right for
Treatment-naïve Severe Aplastic Anemia
Qilu Pharmaceutical Co., Ltd. 210
Testing effectiveness (Phase 2)Study completedNCT04328727
What this trial is testing

Combination of Eltrombopag With Immunosuppressive Therapy in East-Asian Patients With Severe Aplastic Anemia

Who this might be right for
Severe Aplastic Anemia (SAA)
Novartis Pharmaceuticals 36

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation